Back to results
US 9,518,127 B2Granted
Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
AssigneesCSL Behring GmbH, CSL Limited
InventorsCon Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
Life of this patent
Estimating the term…
Abstract
The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
Claims22
An anti-Factor XII/XIIa monoclonal antibody or antigen-binding fragment thereof comprising an immunoglobulin heavy chain variable (vH) region and an immunoglobulin light chain variable (vL) region,
- wherein the vH region comprises:
- a heavy chain CDR1 consisting of the sequence of SEQ ID NO:
- 6;
- a heavy chain CDR2 consisting of the sequence of GIX1X2X3X4X5X6TVYADSVKG (SEQ ID NO:
- 8), wherein X1 is R, N, or D;
- X2 is P, V, I, or M;
- X3 is S, P, or A;
- X4 is G, L, V, or T;
- X5 can be any amino acid;
- and X6 is T, G, or S;
- and
- a heavy chain CDR3 consisting of the sequence of ALPRSGYLX1X2X3X4YYYYALDV (SEQ ID NO:
- 10), wherein X1 is I, M, or V;
- X2 is S or K;
- X3 is P, K, T, or H;
- and X4 is H, N, G, or Q;
- and
- wherein the vL region comprises:
- a light chain CDR1 consisting of the sequence set forth in any one of SEQ ID NOs:
- 11 and 44-51;
- a light chain CDR2 consisting of the sequence of SEQ ID NO:
- 12;
- and
- a light chain CDR3 consisting of the sequence of AX1WX2X3X4X5RX6X7 (SEQ ID NO:
- 14), wherein X1 is A or S;
- X5 is L or V;
- X6 is G, L, or K;
- and X2, X3, X4 and X7 can be any amino acid.
25 more elements
Dependencies are inferred from the claim text.